Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAIN-A: Maintenance Everolimus + AIs vs AIs in HR+ Metastatic Breast Cancer
NCT02511639Phase 3Completed
- Sponsor
- Istituto Oncologico Veneto
- Start
- Jul 2014
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in breast cancer, sponsored by Istituto Oncologico Veneto. Started Jul 2014; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02511639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02511639.